<- Go Home
Precipio, Inc.
Precipio, Inc., a healthcare biotechnology company, provides cancer diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers HemeScreen, a suite of robust genetic diagnostic panels; and IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages. It offers biomarker testing and clinical project services to bio-pharma customers. Precipio, Inc. is based in New Haven, Connecticut.
Market Cap
$39.6M
Volume
14.6K
Cash and Equivalents
$2.6M
EBITDA
-$356.0K
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
$11.3M
Profit Margin
43.71%
52 Week High
$33.63
52 Week Low
$13.80
Dividend
N/A
Price / Book Value
2.79
Price / Earnings
-40.21
Price / Tangible Book Value
11.33
Enterprise Value
$40.4M
Enterprise Value / EBITDA
-722.19
Operating Income
-$1.8M
Return on Equity
7.13%
Return on Assets
-5.74
Cash and Short Term Investments
$2.6M
Debt
$3.5M
Equity
$14.2M
Revenue
$25.8M
Unlevered FCF
$678.1K
Sector
Health Care Providers and Services
Category
N/A